Kara Claxton

Kara Claxton has a strong background in the clinical and pharmaceutical development industry. Kara is currently working as a Clinical Trial Manager at Scout Bio since July 2020. Prior to that, they spent several years at Boehringer Ingelheim, where they held various roles including Scientist IV Biological Clinical Development, Group Leader Biological Clinical Development, and Scientist III - Biological Clinical Development. In these roles, Kara was responsible for planning and executing non-clinical and clinical studies for licensing vaccines for livestock and companion animals. Kara also collaborated with other departments to ensure the safety and efficacy of these products. Before joining Boehringer Ingelheim, Kara worked at Covance, where they gained experience in CMC Pharmaceutical Development Services and Drug Metabolism. Kara held positions such as Supervisor, Associate Staff Scientist, Study Coordinator, and Study Technician during their time at Covance. Overall, Kara Claxton has a diverse range of experience in the clinical and pharmaceutical development field.

Kara Claxton has a strong educational background in various fields. Kara pursued a Bachelor of Science (BS) in Animal Science from the University of Illinois Urbana-Champaign, completing their degree between 2002 and 2004. Following that, they attended Parkland College from 2000 to 2002, where they obtained a certificate (Cert.) in Equine Management.

Later on, Kara furthered their education by pursuing a Master of Science (MS) in Biotechnology at the University of Wisconsin-Madison. Kara attended the university from 2008 to 2010.

Moreover, in addition to their education, Kara has obtained a Project Management Professional (PMP) certification from the Project Management Institute. However, there is no information available on the specific month and year when they obtained this certification.